Active Ingredient: POSACONAZOLE
Proprietary Name: POSACONAZOLE
Dosage Form; Route of Administration: TABLET, DELAYED RELEASE; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A207355
Product Number: 001
Approval Date: Nov 30, 2022
Applicant Holder Full Name: ACTAVIS LABORATORIES FL INC
Marketing Status:
Discontinued
Patent and Exclusivity Information